Literature DB >> 7685458

Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits.

T J Verbeuren1, E Bonhomme, M Laubie, S Simonet.   

Abstract

The aim of our study was to examine the effects of the inhibitor of nitric oxide (NO)-synthase, nitro-L-arginine (L-NNA), in atherosclerotic aortas obtained from cholesterol-fed rabbits. In the atherosclerotic aortas, L-NNA (100 microM) caused endothelium-independent contractions that were not observed in aortas from control rabbits. L-NNA (100 microM) significantly enhanced the contractile responses to norepinephrine and 5-hydroxytryptamine (5-HT) in atherosclerotic aortas with and without endothelium; in control aortas, L-NNA only augmented the response to 5-HT when the endothelium was present. The concentration-dependent increases in the norepinephrine-induced contractions caused by L-NNA (1 to 100 microM) could be reversed by L-arginine (1 mM) both in atherosclerotic aortas with and without endothelium. L-NMMA also evoked concentration-dependent augmentations of the norepinephrine-induced contraction; the effect of L-NMMA was equipotent to that of L-NNA. Finally, L-NNA (100 microM) prevented the paradoxical endothelium-independent contraction to hypoxia in atherosclerotic aortas. These data strongly suggest that nonendothelial NO synthase has been induced in the aortas of the hyperlipidemic rabbit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685458     DOI: 10.1097/00005344-199305000-00023

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

Review 1.  The role of heme oxygenase signaling in various disorders.

Authors:  Arpad Tosaki; Dipak K Das
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Increased activity of guanylate cyclase in the atherosclerotic rabbit aorta: role of non-endothelial nitric oxide synthases.

Authors:  A Rupin; D Behr; T J Verbeuren
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Decreased aortic glutathione levels may contribute to impaired nitric oxide-induced relaxation in hypercholesterolaemia.

Authors:  T Adachi; R A Cohen
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

4.  Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits.

Authors:  I Woditsch; K Schrör
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Sitagliptin ameliorates lipid profile changes and endothelium dysfunction induced by atherogenic diet in rabbits.

Authors:  Manar A Nader
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-05       Impact factor: 3.000

6.  Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta.

Authors:  H Bult; G R De Meyer; A G Herman
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Ethanol potentiates interleukin-1 beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells.

Authors:  W Durante; K Cheng; R K Sunahara; A I Schafer
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Antioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbits.

Authors:  Ahmed R El-Sheakh; Hamdy A Ghoneim; Ghada M Suddek; El-Sayed M Ammar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-09-04       Impact factor: 3.000

9.  Investigation of endogenous nitric oxide vascular function in the carotid artery of cholesterol-fed rabbits.

Authors:  D W Laight; J Matz; B Caesar; M J Carrier; E E Anggård
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

10.  Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis.

Authors:  Volker O Melichar; Delphine Behr-Roussel; Ulrike Zabel; L Otto Uttenthal; José Rodrigo; Alain Rupin; Tony J Verbeuren; Arun Kumar H S; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.